drugset / Trial / NCT02853552

Misoprostol as First Aid Measure to Address Excessive Postpartum Bleeding

NCT02853552

NaSingle-groupOpen-labelHealth-services research

Summary

The overall study purpose is to evaluate the safety, feasibility and acceptability of advance distribution of misoprostol to be used as 'first aid treatment' administered by the woman herself or her family to help treat excessive bleeding in home births.

Timeline

Start
2016-10
Primary completion
2017-10
Completion
2017-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Misoprostol Other / unclassified 800 ug Other

Indications

No indication recorded.